Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32 | 81 | 166 | 95 | 942 |
| Receivables | N/A | 106 | 8 | 127 | 149 |
| TOTAL | $543 | $238 | $282 | $432 | $1,576 |
| Non-Current Assets | |||||
| PPE Net | 73 | 75 | 87 | 74 | 77 |
| Other Non-Current Assets | 29 | 29 | 31 | 31 | 31 |
| TOTAL | $102 | $104 | $118 | $105 | $108 |
| Total Assets | $645 | $342 | $400 | $537 | $1,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,842 | 3,488 |
| Accounts payable and accrued liabilities | 2,563 | 1,751 | 1,041 | 1,241 | 943 |
| Accrued Expenses | 630 | 657 | 453 | 432 | 445 |
| TOTAL | $4,386 | $3,183 | $2,218 | $6,195 | $5,543 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,465 | 2,792 | 2,876 | 3,009 | 3,149 |
| Deferred Revenues | N/A | 13 | 33 | 13 | 39 |
| Other Non-Current Liabilities | 68 | 63 | 57 | 57 | 57 |
| TOTAL | $2,544 | $2,865 | $2,944 | $3,066 | $3,207 |
| Total Liabilities | $6,930 | $6,047 | $5,162 | $9,261 | $8,750 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 567 | 586 | 550 | 535 | 508 |
| Common Shares | 20 | 19 | 16 | 15 | 15 |
| Retained earnings | -56,608 | -54,783 | -51,741 | -47,240 | -44,984 |
| Other shareholders' equity | -482 | -482 | -730 | -500 | -500 |
| TOTAL | $-6,285 | $-5,706 | $-4,762 | $-8,724 | $-7,066 |
| Total Liabilities And Equity | $645 | $342 | $400 | $537 | $1,685 |